6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: October 31, 2019
Period of Report: October 31, 2019
Accession Number: 0001157523-19-002143

View Document ↗ View on SEC.gov ↗